Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Styliani Aggeliki Sintila"'
Autor:
Marina Boziki, Alexandros Pechlivanis, Christina Virgiliou, Christos Bakirtzis, Styliani Aggeliki Sintila, Eleni Karafoulidou, Evangelia Kesidou, Paschalis Theotokis, Ioannis Nikolaidis, Georgios Theodoridis, Helen Gika, Nikolaos Grigoriadis
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 23, p 14578 (2022)
Biomarker research across the health-to-disease continuum is being increasingly applied. We applied blood-based metabolomics in order to identify patient clusters with a first demyelinating episode, and explored the prognostic potential of the method
Externí odkaz:
https://doaj.org/article/2eba9bfbc7ac437ca73c21aa91032f43
Autor:
Marina Boziki, Christos Bakirtzis, Virginia Giantzi, Styliani-Aggeliki Sintila, Stylianos Kallivoulos, Theodora Afrantou, Ioannis Nikolaidis, Panagiotis Ioannidis, Theodoros Karapanayiotides, Ioanna Koutroulou, Dimitrios Parissis, Nikolaos Grigoriadis
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Background: Natalizumab (NTZ) and fingolimod (FTY) are second-line disease modifying treatments (DMTs) approved for Relapsing – Remitting Multiple Sclerosis (RRMS). Few studies are available on a direct comparison between NTZ and FTY, based on post
Externí odkaz:
https://doaj.org/article/d3751aac43a84cf3ae7ca7fd28645be4
Autor:
Panagiotis Stoiloudis, Evangelia Kesidou, Christos Bakirtzis, Styliani-Aggeliki Sintila, Natalia Konstantinidou, Marina Boziki, Nikolaos Grigoriadis
Publikováno v:
Nutrients, Vol 14, Iss 6, p 1150 (2022)
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS) characterized by inflammation and neurodegeneration. The most prominent clinical features include visual loss and sensorimotor symptoms and mainly affects tho
Externí odkaz:
https://doaj.org/article/40ee0ba2e12f404b9bbf2a5ceaa65bf8
Autor:
Paraskevi Iliadou, Christos Bakirtzis, Panagiotis Ioannidis, Katherine Possin, Stelios Zygouris, Styliani-Aggeliki Sintila, Nikolaos Grigoriadis, Eleni Aretouli
Publikováno v:
Journal of Integrative Neuroscience, Vol 21, Iss 1, p 013 (2022)
The hallmark of Multiple Sclerosis (MS) pathophysiology is the damage to the myelin sheath around axons. The cerebellum is a predilection site for demyelination with a well-recognized role in motor and a rather understudied contribution to cognitive
Externí odkaz:
https://doaj.org/article/39152be982f7449989b487babe5e8cca
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 21, p 8409 (2020)
Rare neurological diseases are a heterogeneous group corresponding approximately to 50% of all rare diseases. Neurologists are among the main specialists involved in their diagnostic investigation. At the moment, a consensus guideline on which neurol
Externí odkaz:
https://doaj.org/article/a51d98b731b44177909cfec68bd257d0
Autor:
Evangelia Kesidou, Paschalis Theotokis, Olympia Damianidou, Marina Boziki, Natalia Konstantinidou, Charilaos Taloumtzis, Styliani-Aggeliki Sintila, Panagiotis Grigoriadis, Maria Eleptheria Evangelopoulos, Christos Bakirtzis, Constantina Simeonidou
Publikováno v:
Journal of Clinical Medicine. 12:2255
The process of ageing is characteristic of multicellular organisms associated with late stages of the lifecycle and is manifested through a plethora of phenotypes. Its underlying mechanisms are correlated with age-dependent diseases, especially neuro
Autor:
Christos Bakirtzis, Marina-Kleopatra Boziki, Eleni Grigoriadou, Theodoros Moysiadis, Evangelia Kesidou, Styliani-Aggeliki Sintila, Ioannis Nikolaidis, Natalia Konstantinidou, Paschalis Theotokis, Nikolaos Grigoriadis
Publikováno v:
Multiple Sclerosis and Related Disorders. 71:104347
Autor:
Styliani-Aggeliki Sintila, Marina Boziki, Christos Bakirtzis, Thomai Stardeli, Nikoletta Smyrni, Ioannis Nikolaidis, Dimitrios Parissis, Theodora Afrantou, Theodore Karapanayiotides, Ioanna Koutroulou, Virginia Giantzi, Paschalis Theotokis, Evangelia Kesidou, Georgia Xiromerisiou, Efthimios Dardiotis, Panagiotis Ioannidis, Nikolaos Grigoriadis
Publikováno v:
Medicina
Volume 59
Issue 2
Pages: 266
Volume 59
Issue 2
Pages: 266
Background and Objectives: Rare diseases (RDs) are life-threatening or chronically impairing conditions that affect about 6% of the world’s population. RDs are often called ‘orphan’ diseases, since people suffering from them attract little supp
Autor:
Panagiotis Ioannidis, Virginia Giantzi, Ioannis Nikolaidis, Christos Bakirtzis, Styliani-Aggeliki Sintila, Theodoros Karapanayiotides, Theodora Afrantou, Nikolaos Grigoriadis, Stylianos Kallivoulos, Dimitrios Parissis, Ioanna Koutroulou, Marina Boziki
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Frontiers in Neurology
Frontiers in Neurology
Background: Natalizumab (NTZ) and fingolimod (FTY) are second-line disease modifying treatments (DMTs) approved for Relapsing – Remitting Multiple Sclerosis (RRMS). Few studies are available on a direct comparison between NTZ and FTY, based on post
Autor:
Eleni Aretouli, Nikolaos Grigoriadis, Styliani-Aggeliki Sintila, Stelios Zygouris, Katherine Possin, Panagiotis Ioannidis, Christos Bakirtzis, Paraskevi Iliadou
Publikováno v:
Journal of Integrative Neuroscience, Vol 21, Iss 1, p 013 (2022)
The hallmark of Multiple Sclerosis (MS) pathophysiology is the damage to the myelin sheath around axons. The cerebellum is a predilection site for demyelination with a well-recognized role in motor and a rather understudied contribution to cognitive